Billionaires Citrone, Simons Buy Stakes in Amazon.com, Inc. (AMZN), Facebook Inc (FB), and Priceline Group Inc (PCLN)
Billionaires Rob Citrone and Jim Simons are in harmony as far as the future prospects of Amazon.com, Inc.
Horizon Therapeutics Public Ltd Co (HZNP)
Market is closed
News
- First
- << Previous
- 91 - 100
- Next >>
Deerfield Management's Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)
James Flynn's Deerfield Management has filed its 13F with the SEC for the reporting period of March 31, with the investment manager disclosing a public equity portfolio valued at $3.09 billion.
Horizon Pharma PLC (HZNP), Apple Inc. (AAPL): How Billionaire Mark Kingdon’s Picks Performed in Q1
Kingdon Capital Management, a New-York based hedge fund, was founded by Mark E. Kingdon in 1983. Prior to this, he worked for AT&T and Century Capital Associates.
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross understatement.
Pharmacyclics, Inc. (PCYC), Horizon Pharma PLC (HZNP), Auspex Pharmaceuticals Inc (ASPX): Hedge Fund's Cashing In On Highest Q1 Gainers
The first quarter is up, and our data analytics show that the top three gainers for the quarter were all biotechnology or biopharmaceutical companies and included Pharmacyclics, Inc.
Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains
Kevin Kotler's Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).
Biotech Hedge Fund Deerfield Management's Top Stock Picks
James E. Flynn's Deerfield Management is one of the funds that is focused on the healthcare sector, investing around 70% of its portfolio in healthcare stocks.
Visium Asset Management Raises Exposure To Horizon Pharma Inc. (HZNP)
Visium Asset Management, managed by Jacob Gottlieb, has boosted its position in Horizon Pharma Inc. (NASDAQ:HZNP), a new filing with the U.S. Securities and Exchange Commission showed.
Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Deerfield Management Initiates Passive Stake in Horizon Pharma Inc (HZNP)
James E. Flynn's healthcare-focused Deerfield Management has revealed, in a new filing with the SEC, initiating a passive stake in Horizon Pharma Inc (NASDAQ:HZNP).
- First
- << Previous
- 91 - 100
- Next >>
Billionaire Hedge Funds
